Search company, investor...

Total Raised

$77.99M

Investors Count

9

Deal Terms

5

Funding, Valuation & Revenue

12 Fundings

Zyga Technology has raised $77.99M over 12 rounds.

Zyga Technology's latest funding round was a Acquired for on January 4, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/4/2018

Acquired

$99M

0

FY undefined

1

11/18/2015

Debt - II

$15M

$99M

0

FY undefined

2

11/18/2015

Series D

$5M

$99M

0

FY undefined

2

12/8/2014

Series C - IV

$99M

$99M

0

FY undefined

10

9/25/2014

Debt

$99M

$99M

0

FY undefined

10

Date

1/4/2018

11/18/2015

11/18/2015

12/8/2014

9/25/2014

Round

Acquired

Debt - II

Series D

Series C - IV

Debt

Amount

$15M

$5M

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

2

2

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Zyga Technology Deal Terms

5 Deal Terms

Zyga Technology's deal structure is available for 5 funding rounds, including their Series C - III from September 25, 2014.

Round

Series C - III

Series C - II

Series C

Series B

Series A

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

$99M

$99M

$99M

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series C - III

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series C - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series C

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Zyga Technology Investors

9 Investors

Zyga Technology has 9 investors. RTI Surgical invested in Zyga Technology's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/4/2018

1/4/2018

1
Acquired

Corporation

Florida

00/00/0000

00/00/0000

Split Rock Partners

Subscribe to see more

Venture Capital

Minnesota

00/00/0000

00/00/0000

Domain Associates

Subscribe to see more

Venture Capital

New Jersey

00/00/0000

00/00/0000

MB Venture Partners

Subscribe to see more

Subscribe to see more

Venture Capital

Tennessee

00/00/0000

00/00/0000

Versant Ventures

Subscribe to see more

Venture Capital

California

First funding

1/4/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

1/4/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Split Rock Partners

Domain Associates

MB Venture Partners

Versant Ventures

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

Florida

Minnesota

New Jersey

Tennessee

California

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Zyga Technology to Competitors

N
NanoPowers

NanoPowers aims to develop artificial muscles for various implant indications. The Company has developed several animal proof of concepts, and is entering preclinical stages with devices aimed for the treatment of urinary and fecal incontinences.

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

MicroTransponder Logo
MicroTransponder

MicroTransponder operates as a global medical device company. It develops research-based neuroscience solutions. The company focuses on restoring independence and dignity for people suffering from neurological conditions to impair sensory and motor function. MicroTransponder was founded in 2007 and is based in Austin, Texas.

N
Neotonus

Neotonus is a medical device company which utilizes a non-invasive technology known as Extracorporeal Magnetic Innervation, or ExMI, initially targeted at urinary incontinence.

S
Spinal Restoration

Spinal Restoration focuses on innovative treatments for chronic low back pain within the healthcare sector. The company offers minimally invasive, early intervention therapies aimed at alleviating pain and promoting disc healing without the need for extensive surgery. Spinal Restoration primarily serves patients suffering from chronic back pain and healthcare providers looking for alternative treatment options. It was founded in 2004 and is based in Austin, Texas.

Ogenix Logo
Ogenix

Ogenix specializes in medical devices for wound care, focusing on oxygen therapy treatments. The company's flagship product, EPIFLO, offers a portable oxygen therapy solution that delivers concentrated oxygen directly to wounds to promote healing. EPIFLO is designed for continuous use, enhancing patient independence and potentially reducing overall treatment costs. It is based in Cleveland, Ohio.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.